Mammography has reduced numbers of late-stage breast cancers

In the last 30 years, since mammography was introduced, late-stage breast cancer incidence has decreased by 37%, according to a new study. The analysis takes into account an observed underlying trend of increased breast cancer incidence present since the 1940s, a sort of inflation rate for breast cancer.

Researchers from the University of Michigan Comprehensive Cancer Center in Ann Arbor looked at early-stage and late-stage breast cancer diagnoses between 1977 and -1979, before mammography became popular, and compared it to diagnoses between 2007 and -2009. Based on trends observed in the pre-mammography period of the 1940s to the 1970s as well as continued trends over time, the researchers took into account a central estimated increase in breast cancer incidence of 1.3% per year. This is called an annual percentage change, or APC.

Think of the APC like the inflation rate: $1 from 1977 does not go as far in 2007. Just as the cost of money rises, the number of breast cancer diagnoses is increasing, independently of efforts to detect it earlier.

In the current paper, published in Cancer (2014; doi:10.1002/cncr.28784), the researchers looked at the late 1970s data and projected incidence of early-stage and late-stage breast cancer in 2007 to -2009 based on the APC. They then compared the projected rates to actual rates.

Late-stage breast cancer incidence decreased 37% from the projected rate, and early-stage breast cancer incidence correspondingly increased 48% from 1977- to 1979 to compared with 2007 to -2009. They also conducted similar analyses with other APC values, ranging from 0.5% to 2%. All estimates showed a substantial decrease in late-stage disease.

“When you factor in this temporal trend, our analysis shows that there has been a shift from late-stage to early-stage breast cancer over the last 30 years. This is what you would expect with a successful screening program. Not only are we detecting more early-stage cancer, but we are decreasing the number of late-stage cases that tend to be more challenging to treat and more deadly,” said senior study author Mark Helvie, MD, professor of radiology and director of breast imaging at the University of Michigan-M  Comprehensive Cancer Center.

There are many reasons why breast cancer incidence is increasing over time, including reproductive, dietary, and environmental factors. Prior estimates showed a 1% to -3% annual increase in the United States and Europe before mammography screening began. In countries in Africa, Asia, and Eastern Europe with no routine screening mammography, breast cancer rates are increasing as much as 3% to -5% per each year.

Importantly, the current study also found that since mammography was introduced, invasive breast cancer has had an overall 9% decrease, when factoring in a 1.3% annual percentage increase. This has been offset by an increase in ductal carcinoma in situ, so-called stage 0 breast cancer, which is not invasive.

“While we have seen an increase in overall breast cancer incidence over the last 30 years, the drop in late-stage diagnoses is a positive benefit of mammography and our heightened awareness of early detection. The decrease in late-stage disease, together with improved treatments, contributes to the decreased mortality from breast cancer in the United States in the last 20 years,” Helvie said.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs